$10.11
+0.11 (+1.10%)
Open$9.89
Previous Close$10.00
Day High$10.15
Day Low$9.76
52W High$11.97
52W Low$6.20
Volume—
Avg Volume5.05M
Market Cap1.65B
P/E Ratio—
EPS$-1.54
SectorBiotechnology
Analyst Ratings
Buy
15 analysts
Price Target
+185.7% upside
Current
$10.11
$10.11
Target
$28.88
$28.88
$20.35
$28.88 avg
$29.25
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.13B | 1.37B | 441.16M |
| Net Income | 444.72M | 483.63M | -6,729,988 |
| Profit Margin | 39.2% | 37.2% | -1.5% |
| EBITDA | 456.22M | 523.70M | -8,036,743 |
| Free Cash Flow | — | — | -9,195,591 |
| Rev Growth | -17.2% | -17.2% | +6.7% |
| Debt/Equity | 0.75 | 0.75 | 0.98 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $265.21 | +0.28% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $410.24 | +4.34% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $152.67 | +1.40% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $514.99 | +0.84% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $803.90 | +0.72% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $251.65 | +3.00% | 40.0 | 32.33B |